We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

October 14, 2013

Savient Pharmaceuticals, Inc., et al.,

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. May 19, 2014

    Bankrupt Savient Wins Approval For Ch. 11 Plan

    A Delaware bankruptcy judge on Monday blessed Savient Pharmaceuticals Inc.'s Chapter 11 liquidation plan, allowing the estate of the former drug developer to distribute $120 million in sale proceeds and other remaining assets among its creditors.

6 other articles on this case. View all »

Parties

To view the parties, register now.